South African executive scores big with $55-million gain from Aspen Pharmacare
South African executive Michael Guy Attridge (Gus Attridge) has witnessed a remarkable year-to-date gain of more than $55 million from his stake in Aspen Pharmacare
Aspen Pharmacare
5 South Africans who founded billion-dollar pharma companies
Billionaires.Africa shines a spotlight on five South African trailblazers who have propelled South Africa onto the global stage of medical innovation.
Gus Attridge gains $55 million from investment in Aspen
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharma company.
South African billionaire-led firm to snap up Viagra and others for $280 million
Aspen Pharmacare is a branded pharmaceutical company.
South African billionaire Stephen Saad’s Aspen Pharma stake falls by $29 million in 27 days
Saad’s stake in Aspen Pharma has fallen by $29 million as investors factor in the challenging operating conditions in the pharmaceutical industry.
South African billionaire Stephen Saad rakes in $132 million as Aspen shares skyrocket
With a net worth of $1.2 billion, Saad’s 12.5-percent stake in Aspen Pharmacare accounts for a significant portion of his wealth.
South African pharma tycoon Stephen Saad gains $37.1 million from Aspen shares
Saad owns a significant 12.5-percent stake in Aspen Pharmacare Holdings.
South African billionaire Stephen Saad’s Aspen secures $30 million grant to make vaccines
Aspen Pharmacare Holdings Limited is a South African multinational pharmaceutical holding company.
South African exec Gus Attridge loses $10 million in 13 days from stake in Aspen Pharmacare
Attridge owns a 4.26-percent stake in the company.
South African multimillionaire Gus Attridge’s stake in Aspen now worth $171 million
Aspen Pharmacare is a multinational pharmaceutical holding company.
South African pharma billionaire Stephen Saad’s Aspen closes $1.26-billion credit facility
Aspen Pharmacare Holdings Limited is a South African multinational pharmaceutical holding company.
South African pharma billionaire Stephen Saad’s Aspen signs vaccines deal with India’s Serum Institute
Saad owns a 12.5-percent stake in Aspen worth $566 million.
South African-born billionaire Patrick Soon-Shiong rents out part of vaccine plant as demand declines
Earlier this year, ImmunityBio opened a plant in South Africa under the name Nant SA.
South African billionaire Stephen Saad loses more than $250 million from Aspen Pharma stake
Saad owns a 12.5-percent stake in Aspen Pharmacare Holdings, worth $566 million.
South African billionaire Stephen Saad’s Aspen could cut COVID-19 vaccine capacity
Saad controls a 12.5-percent stake in the leading drug company.
South African billionaire Stephen Saad’s Aspen concludes COVID-19 vaccine deal
The vaccine will be marketed as Aspenovax.